Affiliations 

  • 1 Institute of Cytology RAS, 194064, Tikhoretsky Ave 4, St. Petersburg, Russia
  • 2 Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435, St. Malaya Pirogovskaya, 1a, Moscow, Russia
  • 3 Institute of Cytology RAS, 194064, Tikhoretsky Ave 4, St. Petersburg, Russia. Electronic address: evkazn@incras.ru
Biochimie, 2023 Dec 30;222:63-71.
PMID: 38163516 DOI: 10.1016/j.biochi.2023.12.011

Abstract

Disease models based on induced pluripotent stem cells (iPSCs) are in high demand because of their physiological adequacy and well-reproducibility of the pathological phenotype. Nowadays, the most common approach to generate iPSCs is the reprogramming of somatic cells using vectors based on lentivirus or Sendai virus. We have previously shown impairments of calcium signaling including store-operated calcium entry in Huntington's disease-specific iPSCs-based GABA-ergic medium spiny neurons. However, different approaches for iPSCs generation make it difficult to compare the models since the mechanism of reprogramming may influence the electrophysiological properties of the terminally differentiated neurons. Here, we have studied the features of calcium homeostasis in GABA-ergic medium spiny neurons differentiated from iPSCs obtained from fibroblasts of the same donor using different methods. Our data demonstrated that there were no significant differences neither in calcium influx through the store-operated channels, nor in the levels of proteins activating this type of calcium entry in neurons differentiated from iPSCs generated with lenti- and Sendai viruses-based approaches. We also found no differences in voltage-gated calcium entry for these neurons. Thus, we clearly showed that various methods of cell reprogramming result in similar deregulations in neuronal calcium signaling which substantiates the ability to combine the experimental data on functional studies of ion channels in models based on iPSCs obtained by different methods and expands the prospects for the use of biobanking.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.